Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4517_Библиотеки_им_академика_М_И_Перельмана
.pdf
384
https://t.me/medicina_free
DYSPHAGIA ASSESSMENT AND TREATMENT PLANNING: A TEAM APPROACH
Myotonic Dystrophy Patient Registry
evaluated 556 DM1 patients and their
symptoms, identifying 48% with dysphagia complaints. Those with myotonic symptoms reported dysphagia at
more than twice the rate of those without myotonia (55.3% vs. 21.9%) (Wood
et al., 2017). The pharynx and UES are
the most affected, and intra-deglutitive and post-deglutitive aspiration of
bolus lead to pneumonia. Aspiration
was detected in greater than 50% of
169 patients with MD (Willaert et al.,
2015). Delayed swallowing gestures
and increase transit time have been
associated with increased risk of aspiration (Leonard et al., 2001). In children,
labial weakness also impairs bolus control (Berggren et al., 2018). Pharyngeal
muscle weakness contributes to poor
bolus transit and can be seen on DSS
as an increasing pharyngeal constriction ratio (Leonard et al., 2011). If pharyngeal outlet obstruction is suspected,
then early DSS examination may be
useful to direct treatment and prevent
pharyngeal deterioration.
Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular
junction (NMJ). It is caused by antibodies against the muscle membrane
of the NMJ, resulting in inadequate
acetylcholine in the junction and poor
muscle contraction. In 85% of MG
patients, anti-AChR (nicotinic acetylcholine receptor) antibodies are the
cause, but in 5% to 8% of cases, these
are absent, and instead muscle-specific
kinase (MuSK) antibodies are present (Stathopoulos & Dalakas, 2022).
MuSK-positive patients appear to have
greater prevalence of bulbar symptoms
with dysphagia, dysphonia, and dysar-
thria (Stathopoulos & Dalakas, 2022).
In fact, dysphagia may be the presenting complaint in a quarter of patients
with MG (Berrih-Aknin et al., 2014;
Colton-Hudson et al., 2002; Klair et al.,
2014).
Dysphagia is a source of significant
morbidity and mortality in MG, particularly if the underlying disorder is
unrecognized, which is common particularly if nontypical antibodies are
present. Aspiration may occur and be
silent, risking pulmonary health. DSS
findings include abnormal oral control
of bolus with early spill, residue in the
oral and oropharyngeal cavities, slow
pharyngeal transit, and reduced pharyngeal constriction ratio, penetration,
and aspiration (Colton-Hudson et al.,
2002; Yamamoto et al., 2012). In 20 MG
patients complaining of dysphagia, 13
demonstrated penetration during swallow and 7 demonstrated aspiration, of
whom 4 had silent aspiration (ColtonHudson et al., 2002). Manometry demonstrates esophageal hypomotility and
abnormal UES contraction (Stathopoulos & Dalakas, 2022).
Normal rehabilitative strategies such
as exercises are not effective in MG due
to muscle fatigue, and therefore positioning and dietary modifications may
be more appropriate and should be
guided by DSS examination. Medical
therapy is indicated in MG (typically
pyridostigmine, steroids, azathioprine,
or mycophenylate), and assessment on
medication should be considered so
that diet may be adapted for optimal
function. DSS with edrophonium chloride treatment may assist in making
the diagnosis of MG by demonstrating
changes in pharyngeal parameters with
treatment on board (Yamamoto et al.,
2012). Rituximab therapy for MuSKpositive patients is highly effective and
16. NEUROGENIC DYSPHAGIA
https://t.me/medicina_free
385
indicated as primary treatment in this
group because it depletes B cells in circulation that are producing the autoantibody (Stathopoulos & Dalakas, 2022).
Additional new immune therapies are
in trial and may provide additional
benefit for swallowing.
SUMMARY
Many neurological disorders impact
swallowing safety, efficiency, and vigor.
DSS is a crucial tool in unravelling the
specific abnormalities present and
should be a key feature of full swallowing assessment in these patients.
STUDY QUESTIONS
1. What types of stroke produce dysphagia?
2. Which is more likely to be affected
by stroke: oropharynx or hypopharynx function for swallowing?
DSS in an acute stroke patient?
Should DSS be repeated in acute
stroke patients, and if so, when?
4. What are typical features of dysphagia in head-injured patients?
5. Have significant features of swallowing difficulty been identified for
patients with muscular dystrophy?
Multiple sclerosis? Polymyositis or
dermatomyositis?
6. Do patients with neurological
causes of oropharyngeal dysphagia
respond to swallowing therapy?
7. Do patients with neurological
causes of oropharyngeal dysphagia
respond to surgical therapy?
8. Can DSS help identify who might
benefit most from surgery to
the upper esophageal sphincter
in patients with inclusion body
myositis?
9. If a DSS is recommended for a
patient with Parkinson’s disease,
what might the clinician want to
consider in scheduling it?
REFERENCES
Alali, D., Ballard, K., Vucic, S., & Bogaardt,
H. (2018). Dysphagia in multiple sclerosis: Evaluation and validation of the
DYMUS questionnaire. Dysphagia, 33,
273–281.
Altman, K. W., Yu, G. P., & Schaefer, S. D.
(2010). Consequence of dysphagia in the
hospitalized patient. Archives of Otolaryn-
gology-Head Neck Surgery, 136, 784–789.
Ansari, N. N., Tarameshlu, M., & Ghelichi,
L. (2020). Dysphagia in multiple sclerosis patients: Diagnostic and evaluation
strategies. Degenerative Neurological and
Neuromuscular Disease, 10, 15–28.
Aydogdu, I., Tanriverdi, Z., & Ertekin, C.
(2011). Dysfunction of bulbar central
pattern generator in ALS patients with
dysphagia during sequential deglutition.
Clinical Neurophysiology, 122, 1219–1228.
Azola, A., Mulheren, R., Mckeon, G., Lloyd,
T., Christopher-Stine, L., Palmer, J., &
Chung, T. H. (2020). Dysphagia in myositis: A study of the structural and physiological changes resulting in disordered
swallowing. American Journal of Physical
Medicine & Rehabilitation, 99, 404–408.
Benfer, K. A., Weir, K. A., Bell, K. L., Nahar,
B., Ware, R. S., Davies, P. S. W., & Boyd,
R. N. (2017). Oropharyngeal dysphagia
in children with cerebral palsy: Comparisons between a high and low resource
country. Disability and Rehabilitation, 39,
2404–2412.
Bergamaschi, R., Rezzani, C., Minguzzi, S.,
Amato, M. P., Patti, F., & Marrosu, M. G.,
. . . DYMUS Group. (2009). Validation of
the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.
Functional Neurology, 24, 159–162.
386
https://t.me/medicina_free
DYSPHAGIA ASSESSMENT AND TREATMENT PLANNING: A TEAM APPROACH
Berggren, K. N., Hung, M., Dixon, M. M.,
Bounsanga, J., Crockett, B., Foye, M.
D., . . . Johnson, N. E. (2018). Orofacial
strength, dysarthria, and dysphagia in
congenital myotonic dystrophy. Muscle
Nerve, 58, 413–417.
Berrih-Aknin, S., Frenkian-Cuvelier, M., &
Eymard, B. (2014). Diagnostic and clinical classification of autoimmune myasthenia gravis. Journal of Autoimmunity,
48–49, 143–148.
Birnkrant, D. J., Bushby, K., Bann, C. M.,
Apkon, S. D., Blackwell, A., Brumbaugh, D., . . . DMD Care Considerations
Working Group. (2018). Diagnosis and
management of Duchenne muscular
dystrophy Part 1: Diagnosis, and neuromuscular, rehabilitation, endocrine and
gastrointestinal and nutritional management. The Lancet Neurology, 17, 251–267.
Braak, H., & Del Tredici, K. (2003). Neuro-
pathological staging of brain pathology
in sporadic Parkinson’s disease: Separating the wheat from the chaff. Journal of
Parkinson’s Disease, 7(s1), S71–S85.
Brown, C. V. R., Hejl, K., Mandaville, A. D.,
Chaney, P. E., Stevenson, G., & Smith,
C. (2011). Swallowing dysfunction
after mechanical ventilation in trauma
patients. Journal of Critical Care, 26(108),
e9–108.e13.
Calcagno, P., Ruoppolo, G., Grasso, M. G.,
De Vincentis, M., & Paolucci, S. (2002).
Dysphagia in multiple sclerosis
lence and prognostic factors. Acta Neuro-
logica Scandinavica, 105, 40–43.
Carbo, A., Brown, M., & Nakrour, N. (2021).
Fluoroscopic swallowing examination:
Radiologic findings and analysis of their
causes and pathophysiologic mechanisms. Radiographics, 41(6), 1733–1749.
Chau, K. H. T., & Kung, C. M. A. (2009).
Patient dose during videofluoroscopy
swallowing studies in a Hong Kong public hospital. Dysphagia, 24, 387–390.
Colton-Hudson, A., Koopman, W. J., Moosa,
T., Smith, D., Bach, D., & Nicolle, M.
(2002). A prospective assessment of the
— preva-
characteristics of dysphagia in myasthenia gravis. Dysphagia, 17, 147–151.
Cosentino, G., Avenali, M., Schindler, A.,
Pizzorni, N., Montomoli, C., Abbruzzese,
G., . . . Alfonsi, E. (2022). A multinational
consensus on dysphagia in Parkinson’s
disease: Screening, diagnosis and prognostic value. Journal of Neurology, 269(3),
1335–1352. https://doi.org/10.1007/s00
415-021-10739-8
Cox, F. M., Vershuuren, J. J., Verbist, B. M.,
Niks, E. H., Winzen, A. R., & Badrising,
U. A. (2009). Detecting dysphagia in
inclusion body myositis. Journal of Neu-
rology, 256, 2009–2013.
Danesh-Sani, S. A., Rahimdoost, A., Soltani,
M., Ghiyasi, M., Haghdoost, N., & SabzaliZanjankhah, S. (2013). Clinical assessment of orofacial manifestations in 500
patients with multiple sclerosis. Jour-
nal of Oral and Maxillofacial Surgery, 71,
290–294.
Dehaghani, S. E., Yadegari, F., Asgari, A.,
Chitsaz, A., & Krami, M. (2016). Brain
regions involved in swallowing: Evidence from stroke patients in a crosssectional study. Journal of Research in
Medical Sciences, 21, 45.
De Stefano, A., Di Giovanni, P., Kulamarva,
G., Gennachi, S., Di Fonzo, F., Sallustio,
V., . . . Dispenza, F. (2020). Oropharyngeal dysphagia in elderly population suffering from mild cognitive impairment
and mild dementia: Understanding the
link. American Journal of Otolaryngology,
41(4), 102501. https://doi.org/10.1016/j
.amjoto.2020.102501
Diamanti, L., Borrelli, P., Dubbioso, R.,
Capasso, M., Morelli, C., Lunetta, C.,
Petrucci, A., . . . DYALS Study Group.
(2022). Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis)
questionnaire for the evaluation of dysphagia in ALS patients. Neurological Sci-
ences, 43(5), 3195–3200. https://doi.org/
10.1007/s10072-021-05775-1
Diniz, P. B., Vanin, G., Xavier, R., & Par-
ente, M. A. (2009). Reduced incidence of
16. NEUROGENIC DYSPHAGIA
https://t.me/medicina_free
387
aspiration with spoon-thick consistency
in stroke patients. Nutrition in Clinical
Practice, 24, 414–418.
Donner, M., Bosma, J., & Robertson, D.
(1985). Anatomy and physiology of the
pharynx. Gastrointestinal Radiology, 10,
196–212.
Ebert, E. C. (2009). The gastrointestinal com-
plications of myositis. Alimentary Phar-
macology and Therapeutics, 31, 359–365.
Ellerston, J. K., Heller, A. C., Houtz, D. R., &
Kendall, K. A. (2016). Quantitative measures of swallowing deficits in patients
with Parkinson’s disease. Annals of Otol-
ogy, Rhinology, and Laryngology, 125(5),
385–392.
Ertekin, C., Aydogdu, I., Yüceyar, N., Kiyli-
oglu, N., Tarlaci, S., & Uludag, B. (2000).
Pathophysiological mechanisms of oropharyngeal dysphagia in amyotrophic
lateral sclerosis. Brain, 123, 125–140.
Ertekin, C., Tarlaci, S., Aydogdu, I., Kiyli-
oglu, N., Yuceyar, N., Secil, Y., & Esmeli,
F. (2002). Electrophysiological evaluation
of pharyngeal phase of swallowing in
patients with Parkinson’s disease. Move-
ment Disorders, 17, 942–949.
Espinosa-Val, M. C., Martin-Martinez, A.,
Graupera, M., Aria, O., Elvira, A., Cabre,
M., . . . Ortega, O. (2020). Prevalence, risk
factors, and complications of oropharyngeal dysphagia in older patients with
dementia. Nutrients, 12, 863. https://doi
.org/10.3390/nu12030863
Feng, M. C., Lin, Y. C., Chang, Y. H., Chen,
C. H., Chiang, H. C., Huang, L. C., &
Yang, Y. H. (2019). The mortality and risk
of aspiration pneumonia related with
dysphagia in stroke patients. Journal of
Stroke and Cerebrovascular Diseases, 28(5),
1381–1387.
Flowers, H. L., Al Harbi, M. A., Mikulis, D.,
Silver, F. L., Rochon, E., Streiner, D., &
Martino, R. (2017). MRI-based neuroanatomical predictors of dysphagia, dysarthria, and aphasia in patients with first
acute ischemic stroke. Cerebrovascular
Diseases Extra, 7, 21–34.
Garon, B. R., Sierzant, T., & Ormiston, C.
(2009). Silent aspiration: Results of 2000
videofluoroscopic evaluations. Journal of
Neuroscience Nursing, 41, 178–187.
González-Fernández, M., & Daniels, S. K.
(2008). Dysphagia in stroke and neurologic disease. Physical Medicine Rehabilita-
tion Clinics of North America, 19, 867–888.
Haak, P., Lenski, M., Hidecker, M. J. C., Li,
M., & Paneth, N. (2009). Cerebral palsy
and aging. Developmental Medicine and
Child Neurology, 51(Suppl. 4), 16–23.
Hamanaka-Kondoh, S., Kondoh, J., Tamine,
K., Hori, K., Fujiwara, S., Maeda, Y., . . .
Ono, T. (2014). Tongue pressure during
swallowing is decreased in patients with
Duchenne muscular dystrophy. Neuro-
muscular Disorders, 24, 474–481.
Hobson, P., & Meara, J. (2018). Mortality and
quality of death certification in a cohort
of patients with Parkinson’s disease and
matched controls in North Wales, UK
at 18 years: A community-based cohort
study. BMJ Open, 8, e018969. https://doi
.org/10.1136/bmjopen-2017-018969
Johnson, E., & McKenzie, S. (1993). Aspiration
pneumonia after stroke. Archives of Physi-
cal Medicine and Rehabilitation, 74, 973–976.
Johnson, E., McKenzie, A., Rosenquist, C.,
Sievers, A., & Liberman, J. (1992). Dysphagia following stroke: Quantitative
evaluation of pharyngeal transit times.
Archives of Physical Medicine and Rehabilitation, 73, 419–423.
Jones, C. A., Colletti, C. M., & Ding, M. C.
(2020). Post-stroke dysphagia: Recent
insights and unanswered questions. Cur-
rent Neurology and Neuroscience Reports,
20(12), 61. https://doi.org/10.1007/s119
10- 020-01081-z
Kägi, G., Leisi, N., Galovic, M., MüllerBa-
umberger, M., Krammer, W., & Weder, B.
(2016). Prolonged impairment of deglutition in supratentorial ischaemic stroke:
The predictive value of Parramatta Hospitals’ Assessment of Dysphagia. Swiss
Medical Weekly, 146, w14355. https://doi
.org/10.4414/smw.2016,14355
388
https://t.me/medicina_free
DYSPHAGIA ASSESSMENT AND TREATMENT PLANNING: A TEAM APPROACH
Kalf, J. G., de Swart, B. J., Bloem, B. R., &
Munneke, M. (2012). Prevalence of oropharyngeal dysphagia in Parkinson’s
disease: A meta-analysis. Parkinsonism
and Related Disorders, 18, 311–315.
Kang, S. H., Kim, D. K., Seo, K. M., & Seo,
J. H. (2011). Usefulness of videofluoroscopic swallow study with mixed consistency food for patients with stroke
and other brain injuries. Journal of Korean
Medical Science, 26, 425–430.
Kim, H., & Suh, Y. (2018). Changes in the
dysphagia and nutritional status of
patients with brain injury. Journal of
Clinical Nursing, 27, 1582–1588.
Klair, J. S., Rochlani, Y. M., & Meena, N. K.
(2014). Myasthenia gravis masquerading
as dysphagia: Unveiled by magnesium
infusion. BMJ Case Reports, 2014. https://
doi.org/10.1136/bcr-2014-204163
Kroon, R. H. M. J. M., Horlings, C. G. C.,
de Swart, B. J. M., van Engelen, B. G. M.,
& Kalf, J. G. (2020). Swallowing, chewing and speaking: Frequently impaired
in oculopharyngeal muscular dystrophy. Journal of Neuromuscular Diseases,
7(4), 483–494. https://doi.org/10.3233/
JAD-200511
Kulisevsky, J., Oliveira, L., & Fox, S. H.
(2018). Update in therapeutic strategies
for Parkinson’s disease. Current Opinion
in Neurology, 31(4), 439–447. https://doi
.org/10.1097/WCO.0000000000000579
Kumar, S., Selim, M. H., & Caplan, L. R.
(2010). Medical complications after
stroke. Lancet Neurology, 9, 105–118.
Langdon, P. C., Mulcahy, K., Shepherd, K.
L., Low, V. H., & Mastaglia, F. (2012).
Pharyngeal dysphagia in inflammatory
muscle diseases resulting from impaired
suprahyoid musculature. Dysphagia, 27,
408–417.
Leonard, R. J., Kendall, K. A., Johnson, R.,
& McKenzie, S. (2001). Swallowing in
myotonic muscular dystrophy: A videofluoroscopic study. Archives of Physical
Medicine and Rehabilitation, 82, 979–985.
Leonard, R., Rees, C. J., Belafsky, P., &
Allen, J. (2011). Fluoroscopic surrogate
for pharyngeal strength: The pharyngeal constriction ratio (PCR). Dysphagia,
26, 13–17.
Luchesi, K. F., Kitamura, S., & Mourão, L.
F. (2015). Dysphagia progression and
swallowing management in Parkinson’s
disease: An observational study. Brazilian
Journal of Otorhinolaryngology, 81, 24–30.
Makhnevich, A., Marziliano, A., Ahmad,
S. E., Ardito, S., Ilyas, A., Qiu, M., . . .
Sinvani, L. (2022). Factors and outcomes
associated with dysphagia in hospitalized persons with dementia. Journal of
the American Medical Directors Association,
23(8), 1354–1359.e2. https://doi.org/
.1016/j.jamda.2021.12.027
Manjaly, J. G., Vaughan-Shaw, P. G., Dale,
O. T., Tyler, S., Corlett, J. C. R., & Frost,
R. A. (2011). Cricopharyngeal dilation for
the long-term treatment of dysphagia in
oculopharyngeal muscular dystrophy.
Dysphagia, 27, 216–220.
Marian, T., Schröder, J., Muhle, P., Claus, I.,
Oelenberg, S., Hamacher, C., . . . Dziewas,
R. (2017). Measurement of oxygen desaturation is not useful for the detection of
aspiration in dysphagic stroke patients.
Cerebrovascular Diseases Extra, i, 44–50.
Mastaglia, F. (2008). Inflammatory muscle
diseases. Neurology India, 56, 263–270.
Melkus, G., Sampaio, M. L., Smith, I. C.,
Rakhra, K. S., Bourque, P. R., Breiner, A.,
. . . Warman-Chardon, J. (2022). Quantitative vs qualitative muscle MRI: Imaging
biomarker in patients with oculopha
ryngeal muscular dystrophy (OPMD).
Neuromuscular Disorders: NMD. Advance
online publication. https://doi.org/10.10
16/j.nmd.2022.09.010
Merola, A., Zibetti, M., Angrisano, S., Rizzi,
L., Ricchi, V., Artusi, C. A., . . . Lopiano,
L. (2011). Parkinson’s disease progression at 30 years: A study of subthalamic
deep brain-stimulated patients. Brain,
134(Pt. 7), 2074–2084.
Miles, A., & Allen, J. (2015). Management
of neurogenic oropharyngeal dysphagia.
Current Opinion in Otolaryngology & Head
and Neck Surgery, 23, 433–439.
10
-
16. NEUROGENIC DYSPHAGIA
https://t.me/medicina_free
389
Miles, A., Moore, S., McFarlane, M., Lee,
F., Allen, J., & Huckabee, M. L. (2013).
Comparison of cough reflex test against
instrumental assessment of aspiration.
Physiology & Behavior, 118, 25.
Moghadam-Kia, S., Oddis, C. V., Ascher-
man, D. P., & Aggarwal, R. (2020). Risk
factors and cancer screening in myositis. Rheumatic Diseases Clinics of North
America, 46(3), 565–576. https://doi.org/
10.1016/j.rdc.2020.05.006
Moradi Vastegani, S., Nasrolahi, A., Gha-
deri, S., Belali, R., Rashno, M., Farzaneh,
M., & Khoshnam, S. E. (2023). Mitochondrial dysfunction and Parkinson’s disease: Pathogenesis and therapeutic strategies. Neurochemical Research, 10.1007/
s11064-023-03904-0. Advance online
publication. https://doi.org/10.1007/s11
064-023-03904-0
Morgan, A. T. (2010). Dysphagia in child-
hood traumatic brain injury: A reflection
on the evidence and its implications for
practice. Developmental Neurorehabilita-
tion, 13, 192–203.
Mu, L., Sobotka, S., Chen, J., Su, H., Sand-
ers, I., Adler, C. H., Beach, T. G., & Arizona Parkinson’s Disease Consortium.
(2013). Alpha-synuclein pathology and
axonal degeneration of the peripheral
motor nerves innervating pharyngeal
muscles in Parkinson disease. Journal of
Neuropathology and Experimental Neurology, 72, 119–129.
Mulcahy, K. P., Langdon, P. C., & Mastaglia,
F. (2012). Dysphagia in inflammatory
myopathy: Self-report, incidence and
prevalence. Dysphagia, 27, 64–69.
Naddaf, E., Barohn R. J., & Dimachkie,
M. M. (2018). Inclusion body myositis:
Update on pathogenesis and treatment.
Neurotherapeutics, 15, 995–1005.
Nakazora, T., Maeda, J., Iwamoto, K.,
Hanashiro, S., Nakamura, Y., Kiyozuka,
T., & Domen, K. (2017). Intervention by
speech therapists to promote oral intake
of patients with acute stroke: A retrospective cohort study. Journal of Stroke
and Cerebrovascular Diseases, 26(3), 480–
487. https://doi.org/10.1016/j.jstroke
cerebrovasdis.2016.12.007
Ney, D., Weiss, J., Kind, A., & Robbins, J.
(2009). Senescent swallowing: Impact,
strategies and interventions. Nutrition in
Clinical Practice, 24, 395–413.
Nicaretta, D. H., Rosso, A. L., Mattos, J. P.,
Maliska, C., & Costa, M. M. (2013). Dysphagia and sialorrhea: The relationship
to Parkinson’s disease. Arquivos de Gas-
troenterologia, 50, 42–49.
Paliwal, V. K., Kalita, J., & Misra, U. K.
(2009). Dysphagia in a patient with bilateral medial medullary infarcts. Dyspha-
gia, 24, 349–353.
Panebianco, M., Marchese-Ragona, R.,
Masiero, S., & Restivo, D. A. (2020). Dysphagia in neurological diseases: A literature review. Neurological Sciences, 41(11),
3067–3073.
Pizzorni, N., Pirola, F., Ciammola, A., &
Schindler, A. (2020). Management of dysphagia in Huntington’s disease: A descriptive review. Neurological Sciences, 41(6),
1405–1417. https://doi.org/
72-020-04265-0
Pooravid, M., Derakhshandeh, F., Etemadi-
far, M., Soleymani, B., Minagar, A., &
Maghzi, A. H. (2010). Oropharyngeal
dysphagia in multiple sclerosis. Multiple
Sclerosis, 16, 362–365.
Printza, A., Boziki, M., Triaridis, S., Kiousi,
V., Arnaoutoglou, M., Constantinidis, J., &
Grigoriadis, N. (2021). Tongue strength,
dysphagia questionnaire, pharyngeal secretions and FEES findings in dysphagia
management in amyotrophic lateral sclerosis. Auris, Nasus, Larynx, 48(4), 672–682.
https://doi.org/ 10.1016/j.anl.2020.10.007
Printza, A., Triaridis, S., Kalaitzi, M., Niko-
laidis, I., Bakirtzis, C., Constantinidis,
J., & Grigoriadis, N. (2020). Dysphagia
prevalence, attitudes, and related quality
of life in patients with multiple sclerosis. Dysphagia, 35(4), 677–684. https://doi
.org/10.1007/s00455-019-10075-0
Ramroop, H., & Cruz, R. (2022). Electrodi-
agnostic evaluation of motor neuron disease.
StatPearls Publishing.
10.1007/s100
390
https://t.me/medicina_free
DYSPHAGIA ASSESSMENT AND TREATMENT PLANNING: A TEAM APPROACH
Ramsey, D., Smithard, D., & Kalra, L. (2005).
Silent aspiration: What do we know?
Dysphagia, 20, 218–225.
Ramsey, D. J. C., Smithard, D. G., & Kalra,
L. (2003). Early assessments of dysphagia and aspiration risk in acute stroke
patients. Stroke, 34, 1252–1257.
Reynolds, K. L., & Guidon, A. C. (2019).
Diagnosis and management of immune
checkpoint inhibitor-associated neurologic toxicity: Illustrative case and review
of the literature. Oncologist, 24, 435–443.
Rodrigues, B., Nóbrega, A. C., Sampaio,
M., Argolo, N., & Melo, A. (2011). Silent
saliva aspiration in Parkinson’s disease.
Movement Disorders, 26, 138–141.
Rogers, B., Arvedson, J., Buck, G., Smart,
P., & Msall, M. (1994). Characteristics
of dysphagia in children with cerebral
palsy. Dysphagia, 9, 69–73.
Rugiu, M. G. (2007). Role of videofluoros-
copy in evaluation of neurologic dysphagia. Acta Otorhinolaryngologica Italica, 27,
306–316.
Sandrini, G., & Nappi, G. (2008). Dysphagia
in multiple sclerosis: From pathogenesis to diagnosis. Neurological Sciences, 29,
S360–S363.
Schimmel, M., Ono, T., Lam, O. L., & Muller,
F. (2017). Orofacial impairment in stroke
patients. Journal of Oral Rehabilitation.
Advance online publication. https://doi
.org/10.1111/joor.12486
Seo, H. G., Yi, Y. G., Choi, Y. A., Leigh, J. H.,
Yi, Y., Kim, K., & Bang, M. S. (2019). Oropharyngeal dysphagia in adults with
dyskinetic cerebral palsy and cervical
dystonia: A preliminary study. Archives
of Physical Medicine and Rehabilitation,
100(3), 495–500.e1. https://doi.org/10.10
16/ j.apmr.2018.05.024
Simons, A., & Hamdy, S. (2017). The use of
brain stimulation in dysphagia management. Dysphagia, 32(2), 209–215.
Smithard, D. G. (2016). Dysphagia manage-
ment and stroke units. Current Physical
Medicine and Rehabilitation Reports, 4,
287–294.
Sohrabi, T., Mirzaei-Behbahani, B., Zadali,
R., Pirhaghi, M., Morozova-Roche, L. A.,
& Meratan, A. A. (2023). Common mechanisms underlying alpha-synucleininduced mitochondrial dysfunction in
Parkinson’s disease. Journal of Molecular
Biology, 167992. Advance online publication. https://doi.org/10.1016/j.jmb.2023
.167992
Speyer, R., Cordier, R., Kim, J. H., Cocks, N.,
Michou, E., & Wilkes-Gillan, S. (2019).
Prevalence of drooling, swallowing, and
feeding problems in cerebral palsy across
the lifespan: A systematic review and
meta-analyses. Developmental Medicine
and Child Neurology, 61(11), 1249–1258.
https://doi.org/10.1111/dmcn.14316
Stathopoulos, P., & Dalakas, M. C. (2022).
Autoimmune neurogenic dysphagia.
Dysphagia, 37, 473–487.
Tabor, L. C., Plowman, E. K., Romero-Clark,
C., & Youssof, S. (2018). Oropharyngeal
dysphagia profiles in individuals with
oculopharyngeal muscular dystrophy.
Neurogastroenterology and Motility, 30(4),
e13251. https://doi.org/10.1111/nmo.
13251
Takizawa, C., Gemmell, E., Kenworthy, J.,
& Speyer, R. (2016). A systematic review
of the prevalence of oropharyngeal dysphagia in stroke, Parkinson’s disease,
Alzheimer’s disease, head injury and
pneumonia. Dysphagia, 2, 434–441.
Tassorelli, C., Bergamaschi, R., Buscone, S.,
Bartolo, M., Furnari, A., Crivelli, P., . . .
Nappi, G. (2008). Dysphagia in multiple
sclerosis: From pathogenesis to diagnosis. Neurological Sciences, 29(Suppl. 4),
S360–S363. https://doi.org/10.1007/s10
072-008-1044-9
Terré-Boliart, R., Orient-López, F., Guevara-
Espinosa, D., Ramón-Rona, S., BernabeuGuitart, M., & Clavé-Civit, P. (2004).
Disfagia orofaríngea en pacientes afectados de esclerosis múltiple [Oropharyngeal dysphagia in patients with multiple
sclerosis]. Revista de Neurologia, 39(8),
707–710.
16. NEUROGENIC DYSPHAGIA
https://t.me/medicina_free
391
Toussaint, M., Davidson, Z., Bouvoie, V.,
Evenepoel, N., Haan, J., & Soudon, P.
(2016). Dysphagia in Duchenne muscular dystrophy: Practical recommendations to guide management. Disability
Tutuian, R. (2010). Adverse effects of drugs
on the esophagus. Best Practice Research
in Clinical Gastroenterology, 24, 91–97.
Videira, P. A. Q., & Castro-Caldas, M.
(2018). Linking glycation and glycosylation with inflammation and mitochondrial dysfunction in Parkinson’s disease.
Frontiers in Neuroscience, 12, 381. https://
doi.org/10.3389/fnins.2018.00381
Vilardell, N., Rofes, L., Nascimento, W. V.,
Muriana, D., Palomeras, E., & Clavé, P.
(2017). Cough reflex attenuation and
swallowing dysfunction in sub-acute
post-stroke patients: Prevalence, risk factors, and clinical outcome. Neurogastroen-
terology and Motility, 29. Advance online
publication. https://doi.org/10.1111/
nmo.12910
Waito, A. A., Steele, C. M., Peladeau-Pigeon,
M., Genge, A., & Argov, Z. (2018). A preliminary videofluoroscopic investigation
of swallowing physiology and function
in individuals with oculopharyngeal
muscular dystrophy (OPMD). Dysphagia,
33, 789–802.
White, G. N., O’Rourke, F., Ong, B. S., Cor-
dato, D. J., & Chan, D. K. Y. (2008). Dysphagia: Causes, assessment, treatment
and management. Geriatrics, 63, 15–20.
Willaert, A., Jorissen, M., & Goeleven, A.
(2015). Swallowing dysfunction in myotonic dystrophy: A retrospective study of
symptomatology and radiographic findings. B-ENT, 11, 249–256.
Williams, R. B., Grehan, M. H., Hersch, M.,
Andre, J., & Cook, I. J. (2003). Biomechanics, diagnosis and treatment outcome
in inflammatory myopathy presenting as
oropharyngeal dysphagia. Gut, 52, 471–
478.
Wood, L., Cordts, I., Atalaia, A., Marini-Bet-
tolo, C., Maddison, P., Phillips, M., . . .
Lochmüller, H. (2017). The UK Myotonic
Dystrophy Patient Registry: Facilitating
and accelerating clinical research. Journal
of Neurology, 264(5), 979–988. https://doi
.org/10.1007/s00415-017-8483-2
Yamamoto, T., Chihara, N., Mori-Yoshimura,
M., & Murata, M. (2012). Videofluorographic detection of anti-muscle-specific
kinase-positive myasthenia gravis. Amer-
ican Journal of Otolaryngology, 33(6), 758–
761.
Yamashita, S. (2021). Recent progress in
oculopharyngeal muscular dystrophy.
Journal of Clinical Medicine, 10(7), 1375.
https://doi.org/10.3390/jcm10071375
Zhang, J., Wu, Y., Huang, Y., Zhang, S., Xu,
L., Huang, X., . . . Huang, Q. (2021). Effect
of the Mendelsohn maneuver and swallowing training in patients with senile
vascular dementia complicated with
dysphagia. The Journal of International
Medical Research, 49(5), 3000605211013198.
https://doi.org/10.1177/030006052110
13198
https://t.me/medicina_free
Dysphagia in Head and
https://t.me/medicina_free
Neck Cancer Patients
Katherine A. Kendall
Successful deglutition depends on sensory input from the muscles and the
mucosal surfaces of the oropharynx
to regulate and fine-tune the sequence
of muscular contractions that results
in a swallow. It makes sense that disruption of the sensory, muscular, or
structural integrity of the oral cavity,
pharynx, and larynx causes dysphagia.
In patients with head and neck cancer,
tumor growth, changes in tissue characteristics secondary to radiation with
or without chemotherapy, and any
surgical procedure involving the head
and neck region, therefore, have the
potential to cause dysphagia. Indeed,
xerostomia and dysphagia are the most
often cited contributors to a decrease in
quality of life for head and neck cancer
patients after the completion of treatment (Wang & Eisbruch, 2016). This
chapter will focus on the swallowing
difficulty experienced by head and
neck cancer patients.
INTRODUCTION
In patients with head and neck cancer, interference with normal swallowing may result from the growth of
the tumor-invading structures, impairing their functioning, or from the
obstructive effects of the tumor itself,
which interfere with bolus movement. Surgery to excise the tumor with
a margin of normal tissue typically
results in a defect with loss of structures needed for normal deglutition.
The method chosen for reconstruction
of the defect will subsequently influence the restoration of normal anatomic contours and function. Thus, the
reconstruction affects the character and
the severity of the resultant dysphagia.
When postoperative radiation therapy
is added to the regimen, dysphagia
may worsen secondary to xerostomia
and fibrosis of soft tissues in the field
of radiation exposure, especially if
393
Соседние файлы в папке Библиотека им академика М.И. Перельмана